Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Raven SR, Chevron and Hyzon Motors Collaborate to Produce Hydrogen from Green Waste in Northern Californiahttp://intelligents.wpengine.netdna-cdn.com/wp-content/uploads/2011/04/chevron-corporation-logo.png: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/11090/chevron-corporation-logo.png
Raven SR, Chevron and Hyzon Motors Collaborate to Produce Hydrogen from Green Waste in Northern California


Raven SR Inc. (Raven SR), a renewable fuels company, Chevron New Energies, a division of Chevron U.S.A. Inc., and Hyzon Motors Inc. (NASDAQ: HYZN) today announced they are collaborating to

Immersion Signs Agreement to Make Haptic Technology Licenses Available Through Vishay Intertechnology: https://mms.businesswire.com/media/20191120005233/en/479102/5/Immersion_H_90K.jpg
Immersion Signs Agreement to Make Haptic Technology Licenses Available Through Vishay Intertechnology


Immersion Corporation (NASDAQ: IMMR), a leading developer and provider of technologies for haptics, today announced it has signed a license agreement with Vishay Intertechnology, Inc. (NYSE

VICI Properties Inc. Completes Acquisition of Remaining 49.9% Interest in MGM Grand Las Vegas and Mandalay Bay Joint Venture: https://mms.businesswire.com/media/20201118006119/en/840126/5/caesars+logo_highres.jpg
VICI Properties Inc. Completes Acquisition of Remaining 49.9% Interest in MGM Grand Las Vegas and Mandalay Bay Joint Venture


VICI Properties Inc. (NYSE: VICI) (“VICI Properties” or the “Company”), an experiential real estate investment trust, announced today that the Company has closed on the previously announced

Puma Biotechnology Releases Updated Corporate Presentation: https://mms.businesswire.com/media/20191106005906/en/305625/5/puma_logo_JPEG.jpg
Puma Biotechnology Releases Updated Corporate Presentation


Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, provided an update to the corporate presentation that its Chief Executive Officer and President, Alan H. Auerbach, will refer

Scholar Rock Provides Corporate Update and Highlights Priorities for 2023: https://mms.businesswire.com/media/20211102005274/en/922183/5/Logo_2020.jpg
Scholar Rock Provides Corporate Update and Highlights Priorities for 2023


Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today provided

UDR Named to Newsweek’s 2023 List of America’s Most Responsible Companies: https://mms.businesswire.com/media/20191202005772/en/759858/5/UDR_-_Opening_Doors_to_the_Future_Logo_-_Trademarked.jpg
UDR Named to Newsweek’s 2023 List of America’s Most Responsible Companies


UDR, Inc. (the “Company”) (NYSE: UDR), a leading multifamily real estate investment trust and GRESB 5 Star rated company for its sustainability leadership, announced today that it has been named

Xencor Highlights 2023 Corporate Priorities and Provides Portfolio Updates: https://mms.businesswire.com/media/20191105006084/en/713581/5/Xencor_RGB_fullcolor.jpg
Xencor Highlights 2023 Corporate Priorities and Provides Portfolio Updates


Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced 2023

Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook


DexCom, Inc. (Nasdaq: DXCM), the leader in real-time continuous glucose monitoring (“CGM”), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31

Dexcom Appoints Teri Lawver as Chief Commercial Officer: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Appoints Teri Lawver as Chief Commercial Officer


DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the appointment of Teri Lawver to the newly created role of chief

VICI Properties Inc. Acquires Four Canadian Gaming Properties in Sale Leaseback Transaction With Pure Canadian Gaming Corp.: https://mms.businesswire.com/media/20201118006119/en/840126/5/caesars+logo_highres.jpg
VICI Properties Inc. Acquires Four Canadian Gaming Properties in Sale Leaseback Transaction With Pure Canadian Gaming Corp.


VICI Properties Inc. (NYSE: VICI) (“VICI Properties” or “VICI”), an experiential real estate investment trust, announced today that it has acquired the real estate assets of PURE Casino Edmonton in

Novocure Announces Preliminary Full Year and Fourth Quarter 2022 Net Revenues and Provides Company Update: https://mms.businesswire.com/media/20191120005453/en/721126/5/novocure_main%405x.jpg
Novocure Announces Preliminary Full Year and Fourth Quarter 2022 Net Revenues and Provides Company Update


Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial results and operational updates for the quarter and full year ended December 31, 2022. Novocure is a global oncology company

Essex Announces Release and Conference Call Dates for Its Fourth Quarter 2022 Earnings: https://mms.businesswire.com/media/20191108005660/en/625771/5/Essex_Logo_Black_%28002%29.jpg
Essex Announces Release and Conference Call Dates for Its Fourth Quarter 2022 Earnings


Essex Property Trust, Inc. (NYSE:ESS) announced today that it plans to release its fourth quarter 2022 earnings after the market closes on Tuesday, February 7, 2023. A conference call with senior

QuidelOrtho Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022


QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and

Royal Gold to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series on Wednesday, January 11: https://mms.businesswire.com/media/20191106005902/en/190143/5/Royal_Gold_Logo_-_no_shadow_-_Mar_07.jpg
Royal Gold to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series on Wednesday, January 11


ROYAL GOLD, INC. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that management will present in the live Virtual Non-Deal Roadshow

First Business Bank Announces Leadership Promotions: https://mms.businesswire.com/media/20200123005785/en/686659/5/Fb_logo.jpg
First Business Bank Announces Leadership Promotions


First Business Financial Services, Inc. (the “Company”, the “Bank”, or “First Business Bank”) (Nasdaq:FBIZ) announced promotions among its commercial banking team, advancing key leaders across its

Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications:
Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications


Agilent Technologies, Inc. (NYSE: A) today announced a partnership with Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, to develop multiplex-immunohistochemistry diagnostic

U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine in Infants and Childrenhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine in Infants and Children


Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for priority review a supplemental Biologics License Application (sBLA) for its 20-valent

Redfin Reports Pending Sales Drop to Lowest Level Since at Least 2015: https://mms.businesswire.com/media/20221109005873/en/1407505/5/Redfin_Standard_Web_Logo.jpg
Redfin Reports Pending Sales Drop to Lowest Level Since at Least 2015


(NASDAQ: RDFN) —Pending U.S. home sales dropped 32% year over year to their lowest level since at least 2015 during the four weeks ending January 1, according to a new report from Redfin (redfin.co

Kopin Corporation to Present at the 25th Annual Needham Growth Conference
Kopin Corporation to Present at the 25th Annual Needham Growth Conference


Kopin Corporation (NASDAQ:KOPN), a leading developer of innovative technologies and critical components for wearable computing systems, announced today that Mr. Michael Murray, Chief Executive

Brown-Forman Completes Acquisition of Diplomático Rum Brand: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24292/Brown%E2%80%93Forman_logo.svg.png
Brown-Forman Completes Acquisition of Diplomático Rum Brand


Brown-Forman Corporation (NYSE:BFA,BFB) announced today that it has completed its acquisition of the Diplomático Rum brand and related assets from Destillers United Group S.L. (Spain). The company

New Mountain Finance Corporation Schedules its Fourth Quarter and Year Ended December 31, 2022 Earnings Release and Conference Call: https://mms.businesswire.com/media/20220225005566/en/817636/5/NMFC_Header_Logo.jpg
New Mountain Finance Corporation Schedules its Fourth Quarter and Year Ended December 31, 2022 Earnings Release and Conference Call


New Mountain Finance Corporation (Nasdaq: NMFC) (“New Mountain” or “the Company”) announced today that it will release financial results for the quarter and year ended December 31, 2022 on Monday

Atmos Energy Corporation to Host Fiscal 2023 First Quarter Earnings Conference Call on February 8, 2023: https://mms.businesswire.com/media/20191106005730/en/11463/5/Atmos_Energy.jpg
Atmos Energy Corporation to Host Fiscal 2023 First Quarter Earnings Conference Call on February 8, 2023


Atmos Energy Corporation (NYSE: ATO) will host a conference call on Wednesday, February 8, 2023, at 9:00 a.m. Eastern to review the company’s Fiscal 2023 first quarter financial results. Atmos

Franklin Covey Reports Strong First Quarter Results to Start Fiscal 2023: https://mms.businesswire.com/media/20191107006016/en/664419/5/fc_tuca_logo_color.jpg
Franklin Covey Reports Strong First Quarter Results to Start Fiscal 2023


Franklin Covey Co. (NYSE: FC), a leader in organizational performance improvement that creates, and on a subscription basis, distributes world-class content, training, processes, and tools that

Unit Corporation Declares Special Cash Dividend and Approves Quarterly Cash Dividend Policy:
Unit Corporation Declares Special Cash Dividend and Approves Quarterly Cash Dividend Policy


Unit Corporation (OTC Pink: UNTC) (Company) announced today that its Board of Directors has declared a special cash dividend of $10.00 per share and has approved a quarterly cash dividend policy

Keysight Coordinates Pan-European 6G Testbed: https://mms.businesswire.com/media/20191105005173/en/754303/5/Keysight_Signature_Pref_Color.jpg
Keysight Coordinates Pan-European 6G Testbed


Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that delivers advanced design and validation solutions to help accelerate innovation to connect and secure the world